Background and study aims: We sought to determine whether bispectral index (BIS) monitoring is a useful adjunct to the administration of propofol titrated to deep sedation, as measured by reductions of doses of propofol administered during endoscopic retrograde cholangiopancreatography (ERCP).
Patients and methods: 90 consecutive patients undergoing ERCP were randomized to receive propofol titrated to deep sedation, with the BIS value either visible (BIS group, n = 46) or invisible (control group, n = 44) to the anesthesiologist. In the BIS group, the anesthesiologist was instructed to use the BIS value as the primary end point for titration of sedation, and to target BIS values between 40 and 60. For the control group, the anesthesiologist was instructed to titrate propofol according to routine practice in the unit using the modified Observer’s Assessment of Alertness/Sedation (MOAA/S) Scale (MOAA/S score 0).
Results: The mean (SD) propofol doses (mg/min per kg weight) were 0.139 (0.02) and 0.193 (0.02) for the BIS and control groups, respectively (P < 0.001). Mean (SD) BIS values throughout the procedure were 61.68 (7.5) and 56.93 (4.77) for the BIS and control groups, respectively (P = 0.001). During the maintenance phase of sedation (MOAA/S score 0), the mean (SD) BIS values were 53.73 (8.67) and 45.65 (4.39) for the BIS and control groups, respectively (P < 0.001).
Conclusions: Our data suggest that BIS monitoring led to a reduction in the mean propofol dose when the BIS value was used as the primary target for sedation in ERCP procedures.
References
1
Soehle M, Ellerkmann R K, Grube M. et al .
Comparison between bispectral index and patient state index as measures of the electroencephalographic effects of sevoflurane.
Anesthesiology.
2008;
109
799-805
2
Al-Sammak Z, Al-Falaki M M, Gamal H M.
Predictor of sedation during endoscopic retrograde cholangiopancreatography – bispectral index vs clinical assessment.
Middle East J Anesthesiol.
2005;
18
141-148
3
Chen S C, Rex D K.
An initial investigation of bispectral monitoring as an adjunct to nurse-administered propofol sedation for colonoscopy.
Am J Gastroenterol.
2004;
99
1081-1086
4
Drake L M, Chen S C, Rex D K.
Efficacy of bispectral monitoring as an adjunct to nurse-administered propofol sedation for colonoscopy: a randomized controlled trial.
Am J Gastroenterol.
2006;
101
2003-2007
5
Qadeer M A, Vargo J J, Patel S. et al .
Bispectral index monitoring of conscious sedation with the combination of meperidine and midazolam during endoscopy.
Clin Gastroenterol Hepatol.
2008;
6
102-108
6
Cohen L B.
Patient monitoring during gastrointestinal endoscopy: why, when, and how?.
Gastrointest Endosc Clin N Am.
2008;
18
651-663
7
Bower A L, Ripepi A, Dilger J. et al .
Bispectral index monitoring of sedation during endoscopy.
Gastrointest Endosc.
2000;
52
192-196
8
Krugliak P, Ziff B, Rusabrov Y. et al .
Propofol versus midazolam for conscious sedation guided by processed EEG during endoscopic retrograde cholangiopancreatography: a prospective, randomized, double-blind study.
Endoscopy.
2000;
32
677-682
9
Wehrmann T, Grotkamp J, Stergiou N. et al .
Electroencephalogram monitoring facilitates sedation with propofol for routine ERCP: a randomized, controlled trial.
Gastrointest Endosc.
2002;
56
817-824
10
Riphaus A, Stergiou N, Wehrmann T.
Sedation with propofol for routine ERCP in high-risk octogenarians: a randomized, controlled study.
Am J Gastroenterol.
2005;
100
1957-1963
11
Seifert H, Schmitt T H, Gultekin T. et al .
Sedation with propofol plus midazolam versus propofol alone for interventional endoscopic procedures: a prospective, randomized study.
Aliment Pharmacol Ther.
2000;
14
1207-1214
12
Vargo J J, Zuccaro Jr. G, Dumot J A. et al .
Gastroenterologist-administered propofol versus meperidine and midazolam for advanced upper endoscopy: a prospective, randomized trial.
Gastroenterology.
2002;
123
8-16
13
Wehrmann T, Kokabpick S, Lembcke B. et al .
Efficacy and safety of intravenous propofol sedation during routine ERCP: a prospective, controlled study.
Gastrointest Endosc.
1999;
49
677-683
14
Wysowski D K, Pollock M L.
Reports of death with use of propofol (Diprivan) for nonprocedural (long-term) sedation and literature review.
Anesthesiology.
2006;
105
1047-1051
15
Keats A S.
The ASA classification of physical status – a recapitulation.
Anesthesiology.
1978;
49
233-236
16
Rex D K.
Review article: moderate sedation for endoscopy: sedation regimens for non-anaesthesiologists.
Aliment Pharmacol Ther.
2006;
24
163-171
17
Nelson D B, Barkun A N, Block K P. et al .
Propofol use during gastrointestinal endoscopy.
Gastrointest Endosc.
2001;
53
876-879
18
Aldrete J A, Kroulik D.
A postanesthetic recovery score.
Anesth Analg.
1970;
49
924-934
19
Paspatis G A, Manolaraki M M, Vardas E. et al .
Deep sedation for endoscopic retrograde cholangiopancreatography: intravenous propofol alone versus intravenous propofol with oral midazolam premedication.
Endoscopy.
2008;
40
308-313
20
Zuccaro Jr G.
Sedation and analgesia for GI endoscopy.
Gastrointest Endosc.
2006;
63
95-96
21
Lichtenstein D R, Jagannath S, Baron T H. et al .
Sedation and anesthesia in GI endoscopy.
Gastrointest Endosc.
2008;
68
815-826
22
Imagawa A, Fujiki S, Kawahara Y. et al .
Satisfaction with bispectral index monitoring of propofol-mediated sedation during endoscopic submucosal dissection: a prospective, randomized study.
Endoscopy.
2008;
40
905-909
23
Patel S, Vargo J J, Khandwala F. et al .
Deep sedation occurs frequently during elective endoscopy with meperidine and midazolam.
Am J Gastroenterol.
2005;
100
2689-2695
24
Liu S S.
Effects of bispectral index monitoring on ambulatory anesthesia: a meta-analysis of randomized controlled trials and a cost analysis.
Anesthesiology.
2004;
101
311-315
25
Gan T J, Glass P S, Windsor A. et al .
Bispectral index monitoring allows faster emergence and improved recovery from propofol, alfentanil, and nitrous oxide anesthesia. BIS Utility Study Group.
Anesthesiology.
1997;
87
808-815
26
Myles P S, Leslie K, McNeil J. et al .
Bispectral index monitoring to prevent awareness during anaesthesia: the B-Aware randomised controlled trial.
Lancet.
2004;
363
1757-1763
27
Avidan M S, Zhang L, Burnside B A. et al .
Anesthesia awareness and the bispectral index.
N Engl J Med.
2008;
358
1097-1108
28
Yarchi D, Cohen A, Umansky T. et al .
Assessment of end-tidal carbon dioxide during pediatric and adult sedation for endoscopic procedures.
Gastrointest Endosc.
2009;
69
877-882
29
Cohen L B, Delegge M H, Aisenberg J. et al .
AGA Institute review of endoscopic sedation.
Gastroenterology.
2007;
133
675-701
30
Aisenberg J, Cohen L B, Piorkowski Jr. J D.
Propofol use under the direction of trained gastroenterologists: an analysis of the medicolegal implications.
Am J Gastroenterol.
2007;
102
707-713
31
Heuss L T, Froehlich F, Beglinger C.
Changing patterns of sedation and monitoring practice during endoscopy: results of a nationwide survey in Switzerland.
Endoscopy.
2005;
37
161-166
32
Rex D K, Heuss L T, Walker J A. et al .
Trained registered nurses/endoscopy teams can administer propofol safely for endoscopy.
Gastroenterology.
2005;
129
1384-1391
33
Vargo J J.
Propofol may be safely administered by trained nonanesthesiologists. Pro: Propofol demystified: it is time to change the sedation paradigm.
Am J Gastroenterol.
2004;
99
1207-1208
34
Riphaus A, Wehrmann T, Weber B. et al .
S3-Guideline: Sedation for gastrointestinal endoscopy 2008. AWMF-Register-No. 021/014.
Endoscopy.
2009;
41
787-815
35
Kulling D, Orlandi M, Inauen W.
Propofol sedation during endoscopic procedures: how much staff and monitoring are necessary?.
Gastrointest Endosc.
2007;
66
443-449
G. A. PaspatisMD
Benizelion General Hopsital Department of Gastroenterology
L. Knossou, Heraklion Crete-Greece 71409
Fax: +30-2810-368017
Email: paspati@admin.teiher.gr